{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:33:46Z","timestamp":1789763626700,"version":"4.0.1"},"reference-count":205,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN202620"],"award-info":[{"award-number":["IN202620"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["IN202121"],"award-info":[{"award-number":["IN202121"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["284557"],"award-info":[{"award-number":["284557"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["11614"],"award-info":[{"award-number":["11614"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa de Equipamiento Cient\u00edfico y Tecnol\u00f3gico, Chile","award":["EQM140100"],"award-info":[{"award-number":["EQM140100"]}]},{"name":"Millennium Nucleous for the Study of Pain"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Purinergic Signalling"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11302-021-09785-8","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T22:02:26Z","timestamp":1620856946000},"page":"345-370","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Autocrine and paracrine purinergic signaling in the most lethal types of cancer"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5842-9307","authenticated-orcid":false,"given":"M.","family":"Reyna-Jeldes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9019-8246","authenticated-orcid":false,"given":"M.","family":"D\u00edaz-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Madariaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-3694","authenticated-orcid":false,"given":"C.","family":"Coddou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8248-332X","authenticated-orcid":false,"given":"F. G.","family":"V\u00e1zquez-Cuevas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,12]]},"reference":[{"key":"9785_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.gsf.2017.07.007","volume":"9","author":"NMS Kitadai","year":"2018","unstructured":"Kitadai NMS (2018) Origins of building blocks of life: a review. Geosci Front 9:1117\u20131153","journal-title":"Geosci Front"},{"key":"9785_CR2","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/poc.1668","volume":"23","author":"EDKB Raczynska","year":"2010","unstructured":"Raczynska EDKB (2010) Prototopy and \u03c0-electron delocalization for purines and its radical ions\u2014DFT studies. J Phys Org Chem 23:828\u2013835","journal-title":"J Phys Org Chem"},{"key":"9785_CR3","doi-asserted-by":"crossref","unstructured":"Henderson JFPA (1973) Chapter 2\u2014configuration and conformation of nucleosides and nucleotides. Nucleotide metabolism\u2014an introduction Academic Press, New York:22\u201327","DOI":"10.1016\/B978-0-12-340550-0.50007-1"},{"issue":"1","key":"9785_CR4","doi-asserted-by":"publisher","first-page":"e87165","DOI":"10.1371\/journal.pone.0087165","volume":"9","author":"MD Nguyen","year":"2014","unstructured":"Nguyen MD, Lee ST, Ross AE, Ryals M, Choudhry VI, Venton BJ (2014) Characterization of spontaneous, transient adenosine release in the caudate-putamen and prefrontal cortex. PLoS One 9(1):e87165. https:\/\/doi.org\/10.1371\/journal.pone.0087165","journal-title":"PLoS One"},{"key":"9785_CR5","doi-asserted-by":"publisher","first-page":"239821281881749","DOI":"10.1177\/2398212818817494","volume":"2","author":"G Burnstock","year":"2018","unstructured":"Burnstock G (2018) Purine and purinergic receptors. Brain Neurosci Adv 2:2398212818817494. https:\/\/doi.org\/10.1177\/2398212818817494","journal-title":"Brain Neurosci Adv"},{"key":"9785_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuropharm.2015.12.001","volume":"104","author":"KA Jacobson","year":"2016","unstructured":"Jacobson KA, Muller CE (2016) Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology 104:31\u201349. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.12.001","journal-title":"Neuropharmacology"},{"key":"9785_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12935-020-01195-x","volume":"20","author":"LL Feng","year":"2020","unstructured":"Feng LL, Cai YQ, Zhu MC, Xing LJ, Wang X (2020) The yin and yang functions of extracellular ATP and adenosine in tumor immunity. Cancer Cell Int 20:110. https:\/\/doi.org\/10.1186\/s12935-020-01195-x","journal-title":"Cancer Cell Int"},{"issue":"2","key":"9785_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11302-005-5303-4","volume":"2","author":"C Stefan","year":"2006","unstructured":"Stefan C, Jansen S, Bollen M (2006) Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal 2(2):361\u2013370. https:\/\/doi.org\/10.1007\/s11302-005-5303-4","journal-title":"Purinergic Signal"},{"issue":"4","key":"9785_CR9","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1007\/s12035-015-9270-7","volume":"53","author":"FF Zimmermann","year":"2016","unstructured":"Zimmermann FF, Altenhofen S, Kist LW, Leite CE, Bogo MR, Cognato GP, Bonan CD (2016) Unpredictable chronic stress alters adenosine metabolism in zebrafish brain. Mol Neurobiol 53(4):2518\u20132528. https:\/\/doi.org\/10.1007\/s12035-015-9270-7","journal-title":"Mol Neurobiol"},{"key":"9785_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yjmcc.2016.02.010","volume":"93","author":"T Novitskaya","year":"2016","unstructured":"Novitskaya T, Chepurko E, Covarrubias R, Novitskiy S, Ryzhov SV, Feoktistov I, Gumina RJ (2016) Extracellular nucleotide regulation and signaling in cardiac fibrosis. J Mol Cell Cardiol 93:47\u201356. https:\/\/doi.org\/10.1016\/j.yjmcc.2016.02.010","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"9785_CR11","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tibs.2005.08.005","volume":"30","author":"C Stefan","year":"2005","unstructured":"Stefan C, Jansen S, Bollen M (2005) NPP-type ectophosphodiesterases: unity in diversity. Trends Biochem Sci 30(10):542\u2013550. https:\/\/doi.org\/10.1016\/j.tibs.2005.08.005","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"9785_CR12","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann H, Zebisch M, Strater N (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8(3):437\u2013502. https:\/\/doi.org\/10.1007\/s11302-012-9309-4","journal-title":"Purinergic Signal"},{"issue":"2","key":"9785_CR13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","volume":"2","author":"SP Colgan","year":"2006","unstructured":"Colgan SP, Eltzschig HK, Eckle T, Thompson LF (2006) Physiological roles for ecto-5'-nucleotidase (CD73). Purinergic Signal 2(2):351\u2013360. https:\/\/doi.org\/10.1007\/s11302-005-5302-5","journal-title":"Purinergic Signal"},{"issue":"2","key":"9785_CR14","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11302-006-9000-8","volume":"2","author":"N Strater","year":"2006","unstructured":"Strater N (2006) Ecto-5'-nucleotidase: Structure function relationships. Purinergic Signal 2(2):343\u2013350. https:\/\/doi.org\/10.1007\/s11302-006-9000-8","journal-title":"Purinergic Signal"},{"issue":"Pt 24","key":"9785_CR15","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1242\/jcs.128868","volume":"126","author":"M Colombo","year":"2013","unstructured":"Colombo M, Moita C, van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita LF, Thery C, Raposo G (2013) Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci 126(Pt 24):5553\u20135565. https:\/\/doi.org\/10.1242\/jcs.128868","journal-title":"J Cell Sci"},{"issue":"10","key":"9785_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1586\/14737159.2015.1071666","volume":"15","author":"TL Whiteside","year":"2015","unstructured":"Whiteside TL (2015) The potential of tumor-derived exosomes for noninvasive cancer monitoring. Expert Rev Mol Diagn 15(10):1293\u20131310. https:\/\/doi.org\/10.1586\/14737159.2015.1071666","journal-title":"Expert Rev Mol Diagn"},{"issue":"2","key":"9785_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1742-4658.2008.06793.x","volume":"276","author":"C Volonte","year":"2009","unstructured":"Volonte C, D'Ambrosi N (2009) Membrane compartments and purinergic signalling: the purinome, a complex interplay among ligands, degrading enzymes, receptors and transporters. FEBS J 276(2):318\u2013329. https:\/\/doi.org\/10.1111\/j.1742-4658.2008.06793.x","journal-title":"FEBS J"},{"issue":"3","key":"9785_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","volume":"36","author":"F Di Virgilio","year":"2017","unstructured":"Di Virgilio F, Adinolfi E (2017) Extracellular purines, purinergic receptors and tumor growth. Oncogene 36(3):293\u2013303. https:\/\/doi.org\/10.1038\/onc.2016.206","journal-title":"Oncogene"},{"key":"9785_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.neuint.2014.03.014","volume":"73","author":"A Dos Santos-Rodrigues","year":"2014","unstructured":"Dos Santos-Rodrigues A, Grane-Boladeras N, Bicket A, Coe IR (2014) Nucleoside transporters in the purinome. Neurochem Int 73:229\u2013237. https:\/\/doi.org\/10.1016\/j.neuint.2014.03.014","journal-title":"Neurochem Int"},{"issue":"5","key":"9785_CR20","first-page":"1016","volume":"7","author":"YA Fouad","year":"2017","unstructured":"Fouad YA, Aanei C (2017) Revisiting the hallmarks of cancer. Am J Cancer Res 7(5):1016\u20131036","journal-title":"Am J Cancer Res"},{"issue":"4","key":"9785_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/s0143-4160(96)90039-1","volume":"20","author":"MT Clunes","year":"1996","unstructured":"Clunes MT, Kemp PJ (1996) P2u purinoceptor modulation of intracellular Ca2+ in a human lung adenocarcinoma cell line: down-regulation of Ca2+ influx by protein kinase C. Cell Calcium 20(4):339\u2013346. https:\/\/doi.org\/10.1016\/s0143-4160(96)90039-1","journal-title":"Cell Calcium"},{"issue":"2","key":"9785_CR22","doi-asserted-by":"publisher","first-page":"L376","DOI":"10.1152\/ajplung.00447.2002","volume":"285","author":"R Schafer","year":"2003","unstructured":"Schafer R, Sedehizade F, Welte T, Reiser G (2003) ATP- and UTP-activated P2Y receptors differently regulate proliferation of human lung epithelial tumor cells. Am J Phys Lung Cell Mol Phys 285(2):L376\u2013L385. https:\/\/doi.org\/10.1152\/ajplung.00447.2002","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"4","key":"9785_CR23","doi-asserted-by":"publisher","first-page":"L726","DOI":"10.1152\/ajplung.2000.278.4.L726","volume":"278","author":"DM Zhao","year":"2000","unstructured":"Zhao DM, Xue HH, Chida K, Suda T, Oki Y, Kanai M, Uchida C, Ichiyama A, Nakamura H (2000) Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. Am J Phys Lung Cell Mol Phys 278(4):L726\u2013L736. https:\/\/doi.org\/10.1152\/ajplung.2000.278.4.L726","journal-title":"Am J Phys Lung Cell Mol Phys"},{"issue":"Pt 1","key":"9785_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1113\/jphysiol.2007.139840","volume":"584","author":"SM Kreda","year":"2007","unstructured":"Kreda SM, Okada SF, van Heusden CA, O'Neal W, Gabriel S, Abdullah L, Davis CW, Boucher RC, Lazarowski ER (2007) Coordinated release of nucleotides and mucin from human airway epithelial Calu-3 cells. J Physiol 584(Pt 1):245\u2013259. https:\/\/doi.org\/10.1113\/jphysiol.2007.139840","journal-title":"J Physiol"},{"issue":"Pt 21","key":"9785_CR25","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1242\/jcs.104976","volume":"125","author":"E Takai","year":"2012","unstructured":"Takai E, Tsukimoto M, Harada H, Sawada K, Moriyama Y, Kojima S (2012) Autocrine regulation of TGF-beta1-induced cell migration by exocytosis of ATP and activation of P2 receptors in human lung cancer cells. J Cell Sci 125(Pt 21):5051\u20135060. https:\/\/doi.org\/10.1242\/jcs.104976","journal-title":"J Cell Sci"},{"issue":"3","key":"9785_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s11302-014-9411-x","volume":"10","author":"E Takai","year":"2014","unstructured":"Takai E, Tsukimoto M, Harada H, Kojima S (2014) Autocrine signaling via release of ATP and activation of P2X7 receptor influences motile activity of human lung cancer cells. Purinergic Signal 10(3):487\u2013497. https:\/\/doi.org\/10.1007\/s11302-014-9411-x","journal-title":"Purinergic Signal"},{"issue":"3","key":"9785_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.lungcan.2015.10.005","volume":"90","author":"S Schmid","year":"2015","unstructured":"Schmid S, Kubler M, Korcan Ayata C, Lazar Z, Haager B, Hossfeld M, Meyer A, Cicko S, Elze M, Wiesemann S, Zissel G, Passlick B, Idzko M (2015) Altered purinergic signaling in the tumor associated immunologic microenvironment in metastasized non-small-cell lung cancer. Lung Cancer 90(3):516\u2013521. https:\/\/doi.org\/10.1016\/j.lungcan.2015.10.005","journal-title":"Lung Cancer"},{"key":"9785_CR28","doi-asserted-by":"publisher","unstructured":"Song S, Jacobson KN, McDermott KM, Reddy SP, Cress AE, Tang H, Dudek SM, Black SM, Garcia JG, Makino A, Yuan JX (2016) ATP promotes cell survival via regulation of cytosolic [Ca2+] and Bcl-2\/Bax ratio in lung cancer cells. Am J Phys Cell Phys 310(2):C99\u2013C114. https:\/\/doi.org\/10.1152\/ajpcell.00092.2015","DOI":"10.1152\/ajpcell.00092.2015"},{"issue":"6","key":"9785_CR29","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1177\/0300060516662135","volume":"44","author":"E Tak","year":"2016","unstructured":"Tak E, Jun DY, Kim SH, Park GC, Lee J, Hwang S, Song GW, Lee SG (2016) Upregulation of P2Y2 nucleotide receptor in human hepatocellular carcinoma cells. J Int Med Res 44(6):1234\u20131247. https:\/\/doi.org\/10.1177\/0300060516662135","journal-title":"J Int Med Res"},{"key":"9785_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s12935-019-0973-0","volume":"19","author":"Y Cao","year":"2019","unstructured":"Cao Y, Wang X, Li Y, Evers M, Zhang H, Chen X (2019) Extracellular and macropinocytosis internalized ATP work together to induce epithelial-mesenchymal transition and other early metastatic activities in lung cancer. Cancer Cell Int 19:254. https:\/\/doi.org\/10.1186\/s12935-019-0973-0","journal-title":"Cancer Cell Int"},{"key":"9785_CR31","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12943-015-0469-z","volume":"14","author":"G Schneider","year":"2015","unstructured":"Schneider G, Glaser T, Lameu C, Abdelbaset-Ismail A, Sellers ZP, Moniuszko M, Ulrich H, Ratajczak MZ (2015) Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells. Mol Cancer 14:201. https:\/\/doi.org\/10.1186\/s12943-015-0469-z","journal-title":"Mol Cancer"},{"issue":"2","key":"9785_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1124\/jpet.107.131540","volume":"324","author":"S Ryzhov","year":"2008","unstructured":"Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I, Feoktistov I (2008) Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther 324(2):694\u2013700. https:\/\/doi.org\/10.1124\/jpet.107.131540","journal-title":"J Pharmacol Exp Ther"},{"key":"9785_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fphar.2018.00054","volume":"9","author":"C Giacomelli","year":"2018","unstructured":"Giacomelli C, Daniele S, Romei C, Tavanti L, Neri T, Piano I, Celi A, Martini C, Trincavelli ML (2018) The A2B Adenosine Receptor Modulates the Epithelial- Mesenchymal Transition through the Balance of cAMP\/PKA and MAPK\/ERK Pathway Activation in Human Epithelial Lung Cells. Front Pharmacol 9:54. https:\/\/doi.org\/10.3389\/fphar.2018.00054","journal-title":"Front Pharmacol"},{"issue":"2","key":"9785_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.canlet.2008.01.037","volume":"264","author":"SJ Kim","year":"2008","unstructured":"Kim SJ, Min HY, Chung HJ, Park EJ, Hong JY, Kang YJ, Shin DH, Jeong LS, Lee SK (2008) Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. Cancer Lett 264(2):309\u2013315. https:\/\/doi.org\/10.1016\/j.canlet.2008.01.037","journal-title":"Cancer Lett"},{"issue":"8","key":"9785_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1093\/carcin\/bgr101","volume":"32","author":"M Tafani","year":"2011","unstructured":"Tafani M, Schito L, Pellegrini L, Villanova L, Marfe G, Anwar T, Rosa R, Indelicato M, Fini M, Pucci B, Russo MA (2011) Hypoxia-increased RAGE and P2X7R expression regulates tumor cell invasion through phosphorylation of Erk1\/2 and Akt and nuclear translocation of NF-{kappa}B. Carcinogenesis 32(8):1167\u20131175. https:\/\/doi.org\/10.1093\/carcin\/bgr101","journal-title":"Carcinogenesis"},{"issue":"1","key":"9785_CR36","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3892\/or.2015.3979","volume":"34","author":"J Xia","year":"2015","unstructured":"Xia J, Yu X, Tang L, Li G, He T (2015) P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway. Oncol Rep 34(1):103\u2013110. https:\/\/doi.org\/10.3892\/or.2015.3979","journal-title":"Oncol Rep"},{"issue":"10","key":"9785_CR37","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/nm.2028","volume":"15","author":"F Ghiringhelli","year":"2009","unstructured":"Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL, Schlemmer F, Tasdemir E, Uhl M, Genin P, Civas A, Ryffel B, Kanellopoulos J, Tschopp J, Andre F, Lidereau R, McLaughlin NM, Haynes NM, Smyth MJ, Kroemer G, Zitvogel L (2009) Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med 15(10):1170\u20131178. https:\/\/doi.org\/10.1038\/nm.2028","journal-title":"Nat Med"},{"key":"9785_CR38","doi-asserted-by":"publisher","first-page":"32602","DOI":"10.1038\/srep32602","volume":"6","author":"D Avanzato","year":"2016","unstructured":"Avanzato D, Genova T, Fiorio Pla A, Bernardini M, Bianco S, Bussolati B, Mancardi D, Giraudo E, Maione F, Cassoni P, Castellano I, Munaron L (2016) Activation of P2X7 and P2Y11 purinergic receptors inhibits migration and normalizes tumor-derived endothelial cells via cAMP signaling. Sci Rep 6:32602. https:\/\/doi.org\/10.1038\/srep32602","journal-title":"Sci Rep"},{"issue":"19","key":"9785_CR39","doi-asserted-by":"publisher","first-page":"9322","DOI":"10.18632\/oncotarget.2427","volume":"5","author":"YN Joo","year":"2014","unstructured":"Joo YN, Jin H, Eun SY, Park SW, Chang KC, Kim HJ (2014) P2Y2R activation by nucleotides released from the highly metastatic breast cancer cell MDA-MB-231 contributes to pre-metastatic niche formation by mediating lysyl oxidase secretion, collagen crosslinking, and monocyte recruitment. Oncotarget 5(19):9322\u20139334. https:\/\/doi.org\/10.18632\/oncotarget.2427","journal-title":"Oncotarget"},{"issue":"1-2","key":"9785_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.mce.2011.02.014","volume":"338","author":"HJ Li","year":"2011","unstructured":"Li HJ, Wang LY, Qu HN, Yu LH, Burnstock G, Ni X, Xu M, Ma B (2011) P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol Cell Endocrinol 338(1-2):28\u201337. https:\/\/doi.org\/10.1016\/j.mce.2011.02.014","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"9785_CR41","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/carcin\/bgt493","volume":"35","author":"S Chadet","year":"2014","unstructured":"Chadet S, Jelassi B, Wannous R, Angoulvant D, Chevalier S, Besson P, Roger S (2014) The activation of P2Y2 receptors increases MCF-7 breast cancer cells migration through the MEK-ERK1\/2 signalling pathway. Carcinogenesis 35(6):1238\u20131247. https:\/\/doi.org\/10.1093\/carcin\/bgt493","journal-title":"Carcinogenesis"},{"issue":"1","key":"9785_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3892\/or.2015.3972","volume":"34","author":"SY Eun","year":"2015","unstructured":"Eun SY, Ko YS, Park SW, Chang KC, Kim HJ (2015) P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells. Oncol Rep 34(1):195\u2013202. https:\/\/doi.org\/10.3892\/or.2015.3972","journal-title":"Oncol Rep"},{"issue":"7","key":"9785_CR43","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/cas.13273","volume":"108","author":"JL Zhang","year":"2017","unstructured":"Zhang JL, Liu Y, Yang H, Zhang HQ, Tian XX, Fang WG (2017) ATP-P2Y2-beta-catenin axis promotes cell invasion in breast cancer cells. Cancer Sci 108(7):1318\u20131327. https:\/\/doi.org\/10.1111\/cas.13273","journal-title":"Cancer Sci"},{"issue":"5","key":"9785_CR44","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3892\/ijo.2018.4552","volume":"53","author":"H Jin","year":"2018","unstructured":"Jin H, Ko YS, Kim HJ (2018) P2Y2R-mediated inflammasome activation is involved in tumor progression in breast cancer cells and in radiotherapy-resistant breast cancer. Int J Oncol 53(5):1953\u20131966. https:\/\/doi.org\/10.3892\/ijo.2018.4552","journal-title":"Int J Oncol"},{"issue":"20","key":"9785_CR45","doi-asserted-by":"publisher","first-page":"29036","DOI":"10.18632\/oncotarget.8664","volume":"7","author":"X Ma","year":"2016","unstructured":"Ma X, Pan X, Wei Y, Tan B, Yang L, Ren H, Qian M, Du B (2016) Chemotherapy-induced uridine diphosphate release promotes breast cancer metastasis through P2Y6 activation. Oncotarget 7(20):29036\u201329050. https:\/\/doi.org\/10.18632\/oncotarget.8664","journal-title":"Oncotarget"},{"issue":"1-2","key":"9785_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10585-018-9874-1","volume":"35","author":"AJ Gareau","year":"2018","unstructured":"Gareau AJ, Brien C, Gebremeskel S, Liwski RS, Johnston B, Bezuhly M (2018) Ticagrelor inhibits platelet-tumor cell interactions and metastasis in human and murine breast cancer. Clin Exp Metastasis 35(1-2):25\u201335. https:\/\/doi.org\/10.1007\/s10585-018-9874-1","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"9785_CR47","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.4161\/cbt.4.12.2196","volume":"4","author":"A Mirza","year":"2005","unstructured":"Mirza A, Basso A, Black S, Malkowski M, Kwee L, Pachter JA, Lachowicz JE, Wang Y, Liu S (2005) RNA interference targeting of A1 receptor-overexpressing breast carcinoma cells leads to diminished rates of cell proliferation and induction of apoptosis. Cancer Biol Ther 4(12):1355\u20131360. https:\/\/doi.org\/10.4161\/cbt.4.12.2196","journal-title":"Cancer Biol Ther"},{"issue":"4","key":"9785_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.4149\/bll_2016_046","volume":"117","author":"MN Dastjerdi","year":"2016","unstructured":"Dastjerdi MN, Valiani A, Mardani M, Ra MZ (2016) Adenosine A1 receptor modifies P53 expression and apoptosis in breast cancer cell line Mcf-7. Bratisl Lek Listy 117(4):242\u2013246. https:\/\/doi.org\/10.4149\/bll_2016_046","journal-title":"Bratisl Lek Listy"},{"issue":"12","key":"9785_CR49","doi-asserted-by":"publisher","first-page":"e26705","DOI":"10.4161\/onci.26705","volume":"2","author":"PA Beavis","year":"2013","unstructured":"Beavis PA, Milenkovski N, Stagg J, Smyth MJ, Darcy PK (2013) A2A blockade enhances anti-metastatic immune responses. Oncoimmunology 2(12):e26705. https:\/\/doi.org\/10.4161\/onci.26705","journal-title":"Oncoimmunology"},{"issue":"14","key":"9785_CR50","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","volume":"74","author":"D Mittal","year":"2014","unstructured":"Mittal D, Young A, Stannard K, Yong M, Teng MW, Allard B, Stagg J, Smyth MJ (2014) Antimetastatic effects of blocking PD-1 and the adenosine A2A receptor. Cancer Res 74(14):3652\u20133658. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0957","journal-title":"Cancer Res"},{"issue":"1","key":"9785_CR51","doi-asserted-by":"publisher","first-page":"6035","DOI":"10.1038\/s41598-021-85379-z","volume":"11","author":"N Petruk","year":"2021","unstructured":"Petruk N, Tuominen S, Akerfelt M, Mattsson J, Sandholm J, Nees M, Yegutkin GG, Jukkola A, Tuomela J, Selander KS (2021) CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer. Sci Rep 11(1):6035. https:\/\/doi.org\/10.1038\/s41598-021-85379-z","journal-title":"Sci Rep"},{"issue":"12","key":"9785_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167445","volume":"11","author":"M Fernandez-Gallardo","year":"2016","unstructured":"Fernandez-Gallardo M, Gonzalez-Ramirez R, Sandoval A, Felix R, Monjaraz E (2016) Adenosine stimulate proliferation and migration in triple negative breast cancer cells. PLoS One 11(12):e0167445. https:\/\/doi.org\/10.1371\/journal.pone.0167445","journal-title":"PLoS One"},{"issue":"13","key":"9785_CR53","doi-asserted-by":"publisher","first-page":"5139","DOI":"10.1073\/pnas.1222085110","volume":"110","author":"CJ Desmet","year":"2013","unstructured":"Desmet CJ, Gallenne T, Prieur A, Reyal F, Visser NL, Wittner BS, Smit MA, Geiger TR, Laoukili J, Iskit S, Rodenko B, Zwart W, Evers B, Horlings H, Ajouaou A, Zevenhoven J, van Vliet M, Ramaswamy S, Wessels LF, Peeper DS (2013) Identification of a pharmacologically tractable Fra-1\/ADORA2B axis promoting breast cancer metastasis. Proc Natl Acad Sci U S A 110(13):5139\u20135144. https:\/\/doi.org\/10.1073\/pnas.1222085110","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"9785_CR54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13402-017-0359-z","volume":"41","author":"SM Jafari","year":"2018","unstructured":"Jafari SM, Joshaghani HR, Panjehpour M, Aghaei M (2018) A2B adenosine receptor agonist induces cell cycle arrest and apoptosis in breast cancer stem cells via ERK1\/2 phosphorylation. Cell Oncol (Dordr) 41(1):61\u201372. https:\/\/doi.org\/10.1007\/s13402-017-0359-z","journal-title":"Cell Oncol (Dordr)"},{"issue":"41","key":"9785_CR55","doi-asserted-by":"publisher","first-page":"E9640","DOI":"10.1073\/pnas.1809695115","volume":"115","author":"J Lan","year":"2018","unstructured":"Lan J, Lu H, Samanta D, Salman S, Lu Y, Semenza GL (2018) Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment. Proc Natl Acad Sci U S A 115(41):E9640\u2013E9648. https:\/\/doi.org\/10.1073\/pnas.1809695115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"9785_CR56","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1158\/1078-0432.CCR-03-0651","volume":"10","author":"L Madi","year":"2004","unstructured":"Madi L, Ochaion A, Rath-Wolfson L, Bar-Yehuda S, Erlanger A, Ohana G, Harish A, Merimski O, Barer F, Fishman P (2004) The A3 adenosine receptor is highly expressed in tumor versus normal cells: potential target for tumor growth inhibition. Clin Cancer Res 10(13):4472\u20134479. https:\/\/doi.org\/10.1158\/1078-0432.CCR-03-0651","journal-title":"Clin Cancer Res"},{"issue":"8","key":"9785_CR57","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.biocel.2003.12.001","volume":"36","author":"M Panjehpour","year":"2004","unstructured":"Panjehpour M, Karami-Tehrani F (2004) An adenosine analog (IB-MECA) inhibits anchorage-dependent cell growth of various human breast cancer cell lines. Int J Biochem Cell Biol 36(8):1502\u20131509. https:\/\/doi.org\/10.1016\/j.biocel.2003.12.001","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"9785_CR58","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s11302-016-9531-6","volume":"12","author":"C Ledderose","year":"2016","unstructured":"Ledderose C, Hefti MM, Chen Y, Bao Y, Seier T, Li L, Woehrle T, Zhang J, Junger WG (2016) Adenosine arrests breast cancer cell motility by A3 receptor stimulation. Purinergic Signal 12(4):673\u2013685. https:\/\/doi.org\/10.1007\/s11302-016-9531-6","journal-title":"Purinergic Signal"},{"issue":"2","key":"9785_CR59","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ejca.2012.06.005","volume":"49","author":"K Varani","year":"2013","unstructured":"Varani K, Vincenzi F, Targa M, Paradiso B, Parrilli A, Fini M, Lanza G, Borea PA (2013) The stimulation of A(3) adenosine receptors reduces bone-residing breast cancer in a rat preclinical model. Eur J Cancer 49(2):482\u2013491. https:\/\/doi.org\/10.1016\/j.ejca.2012.06.005","journal-title":"Eur J Cancer"},{"issue":"9","key":"9785_CR60","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1002\/jcb.25945","volume":"118","author":"SM Jafari","year":"2017","unstructured":"Jafari SM, Panjehpour M, Aghaei M, Joshaghani HR, Enderami SE (2017) A3 adenosine receptor agonist inhibited survival of breast cancer stem cells via GLI-1 and ERK1\/2 pathway. J Cell Biochem 118(9):2909\u20132920. https:\/\/doi.org\/10.1002\/jcb.25945","journal-title":"J Cell Biochem"},{"issue":"6","key":"9785_CR61","doi-asserted-by":"publisher","first-page":"E1239","DOI":"10.1073\/pnas.1718197115","volume":"115","author":"D Samanta","year":"2018","unstructured":"Samanta D, Park Y, Ni X, Li H, Zahnow CA, Gabrielson E, Pan F, Semenza GL (2018) Chemotherapy induces enrichment of CD47(+)\/CD73(+)\/PDL1(+) immune evasive triple-negative breast cancer cells. Proc Natl Acad Sci U S A 115(6):E1239\u2013E1248. https:\/\/doi.org\/10.1073\/pnas.1718197115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9785_CR62","doi-asserted-by":"publisher","unstructured":"Qiao Z, Li X, Kang N, Yang Y, Chen C, Wu T, Zhao M, Liu Y, Ji X (2019) A novel specific anti-CD73 antibody inhibits triple-negative breast cancer cell motility by regulating autophagy. Int J Mol Sci 20(5). https:\/\/doi.org\/10.3390\/ijms20051057","DOI":"10.3390\/ijms20051057"},{"issue":"20","key":"9785_CR63","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1158\/0008-5472.CAN-17-0707","volume":"77","author":"M Turcotte","year":"2017","unstructured":"Turcotte M, Allard D, Mittal D, Bareche Y, Buisseret L, Jose V, Pommey S, Delisle V, Loi S, Joensuu H, Kellokumpu-Lehtinen PL, Sotiriou C, Smyth MJ, Stagg J (2017) CD73 Promotes Resistance to HER2\/ErbB2 Antibody Therapy. Cancer Res 77(20):5652\u20135663. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0707","journal-title":"Cancer Res"},{"issue":"2","key":"9785_CR64","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/sj.bjp.0703833","volume":"132","author":"R Janssens","year":"2001","unstructured":"Janssens R, Boeynaems JM (2001) Effects of extracellular nucleotides and nucleosides on prostate carcinoma cells. Br J Pharmacol 132(2):536\u2013546. https:\/\/doi.org\/10.1038\/sj.bjp.0703833","journal-title":"Br J Pharmacol"},{"issue":"1","key":"9785_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/B:BREA.0000010670.85915.0f","volume":"83","author":"M Slater","year":"2004","unstructured":"Slater M, Danieletto S, Pooley M, Cheng Teh L, Gidley-Baird A, Barden JA (2004) Differentiation between cancerous and normal hyperplastic lobules in breast lesions. Breast Cancer Res Treat 83(1):1\u201310. https:\/\/doi.org\/10.1023\/B:BREA.0000010670.85915.0f","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"9785_CR66","doi-asserted-by":"publisher","first-page":"e114371","DOI":"10.1371\/journal.pone.0114371","volume":"9","author":"Y Qiu","year":"2014","unstructured":"Qiu Y, Li WH, Zhang HQ, Liu Y, Tian XX, Fang WG (2014) P2X7 mediates ATP-driven invasiveness in prostate cancer cells. PLoS One 9(12):e114371. https:\/\/doi.org\/10.1371\/journal.pone.0114371","journal-title":"PLoS One"},{"issue":"2","key":"9785_CR67","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41388-018-0426-6","volume":"38","author":"SM Gilbert","year":"2019","unstructured":"Gilbert SM, Oliphant CJ, Hassan S, Peille AL, Bronsert P, Falzoni S, Di Virgilio F, McNulty S, Lara R (2019) ATP in the tumour microenvironment drives expression of nfP2X7, a key mediator of cancer cell survival. Oncogene 38(2):194\u2013208. https:\/\/doi.org\/10.1038\/s41388-018-0426-6","journal-title":"Oncogene"},{"issue":"3","key":"9785_CR68","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/j.1464-410X.2007.07293.x","volume":"101","author":"M Shabbir","year":"2008","unstructured":"Shabbir M, Ryten M, Thompson C, Mikhailidis D, Burnstock G (2008) Characterization of calcium-independent purinergic receptor-mediated apoptosis in hormone-refractory prostate cancer. BJU Int 101(3):352\u2013359","journal-title":"BJU Int"},{"issue":"4","key":"9785_CR69","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bcp.2011.05.013","volume":"82","author":"Q Wei","year":"2011","unstructured":"Wei Q, Costanzi S, Liu QZ, Gao ZG, Jacobson KA (2011) Activation of the P2Y1 receptor induces apoptosis and inhibits proliferation of prostate cancer cells. Biochem Pharmacol 82(4):418\u2013425. https:\/\/doi.org\/10.1016\/j.bcp.2011.05.013","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"9785_CR70","doi-asserted-by":"publisher","first-page":"18938","DOI":"10.1038\/s41598-019-55194-8","volume":"9","author":"HTT Le","year":"2019","unstructured":"Le HTT, Rimpilainen T, Konda Mani S, Murugesan A, Yli-Harja O, Candeias NR, Kandhavelu M (2019) Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent. Sci Rep 9(1):18938. https:\/\/doi.org\/10.1038\/s41598-019-55194-8","journal-title":"Sci Rep"},{"issue":"6","key":"9785_CR71","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1038\/bjc.2013.484","volume":"109","author":"WH Li","year":"2013","unstructured":"Li WH, Qiu Y, Zhang HQ, Liu Y, You JF, Tian XX, Fang WG (2013) P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer 109(6):1666\u20131675. https:\/\/doi.org\/10.1038\/bjc.2013.484","journal-title":"Br J Cancer"},{"issue":"7","key":"9785_CR72","doi-asserted-by":"publisher","first-page":"e0133165","DOI":"10.1371\/journal.pone.0133165","volume":"10","author":"WH Li","year":"2015","unstructured":"Li WH, Qiu Y, Zhang HQ, Tian XX, Fang WG (2015) P2Y2 Receptor and EGFR cooperate to promote prostate cancer cell invasion via ERK1\/2 pathway. PLoS One 10(7):e0133165. https:\/\/doi.org\/10.1371\/journal.pone.0133165","journal-title":"PLoS One"},{"issue":"4","key":"9785_CR73","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/pros.21438","volume":"72","author":"M Aghaei","year":"2012","unstructured":"Aghaei M, Karami-Tehrani F, Panjehpour M, Salami S, Fallahian F (2012) Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3. Prostate 72(4):361\u2013375. https:\/\/doi.org\/10.1002\/pros.21438","journal-title":"Prostate"},{"issue":"2","key":"9785_CR74","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11302-012-9350-3","volume":"9","author":"Q Wei","year":"2013","unstructured":"Wei Q, Costanzi S, Balasubramanian R, Gao ZG, Jacobson KA (2013) A2B adenosine receptor blockade inhibits growth of prostate cancer cells. Purinergic Signal 9(2):271\u2013280. https:\/\/doi.org\/10.1007\/s11302-012-9350-3","journal-title":"Purinergic Signal"},{"issue":"5","key":"9785_CR75","doi-asserted-by":"publisher","first-page":"C1349","DOI":"10.1152\/ajpcell.00256.2004","volume":"287","author":"Q Wang","year":"2004","unstructured":"Wang Q, Wang L, Feng YH, Li X, Zeng R, Gorodeski GI (2004) P2X7 receptor-mediated apoptosis of human cervical epithelial cells. Am J Phys Cell Phys 287(5):C1349\u2013C1358. https:\/\/doi.org\/10.1152\/ajpcell.00256.2004","journal-title":"Am J Phys Cell Phys"},{"issue":"9-11","key":"9785_CR76","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1080\/15257770600890921","volume":"25","author":"YH Feng","year":"2006","unstructured":"Feng YH, Li X, Zeng R, Gorodeski GI (2006) Endogenously expressed truncated P2X7 receptor lacking the C-terminus is preferentially upregulated in epithelial cancer cells and fails to mediate ligand-induced pore formation and apoptosis. Nucleosides Nucleotides Nucleic Acids 25(9-11):1271\u20131276. https:\/\/doi.org\/10.1080\/15257770600890921","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"25","key":"9785_CR77","doi-asserted-by":"publisher","first-page":"17228","DOI":"10.1074\/jbc.M602999200","volume":"281","author":"YH Feng","year":"2006","unstructured":"Feng YH, Li X, Wang L, Zhou L, Gorodeski GI (2006) A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. J Biol Chem 281(25):17228\u201317237. https:\/\/doi.org\/10.1074\/jbc.M602999200","journal-title":"J Biol Chem"},{"issue":"10","key":"9785_CR78","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1158\/1055-9965.EPI-06-0407","volume":"15","author":"X Li","year":"2006","unstructured":"Li X, Zhou L, Feng YH, Abdul-Karim FW, Gorodeski GI (2006) The P2X7 receptor: a novel biomarker of uterine epithelial cancers. Cancer Epidemiol Biomark Prev 15(10):1906\u20131913. https:\/\/doi.org\/10.1158\/1055-9965.EPI-06-0407","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"9785_CR79","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/cbf.992","volume":"21","author":"A Okuda","year":"2003","unstructured":"Okuda A, Furuya K, Kiyohara T (2003) ATP-induced calcium oscillations and change of P2Y subtypes with culture conditions in HeLa cells. Cell Biochem Funct 21(1):61\u201368. https:\/\/doi.org\/10.1002\/cbf.992","journal-title":"Cell Biochem Funct"},{"issue":"2","key":"9785_CR80","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1002\/jcp.10242","volume":"195","author":"A Muscella","year":"2003","unstructured":"Muscella A, Elia MG, Greco S, Storelli C, Marsigliante S (2003) Activation of P2Y2 receptor induces c-FOS protein through a pathway involving mitogen-activated protein kinases and phosphoinositide 3-kinases in HeLa cells. J Cell Physiol 195(2):234\u2013240. https:\/\/doi.org\/10.1002\/jcp.10242","journal-title":"J Cell Physiol"},{"issue":"1","key":"9785_CR81","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0898-6568(02)00062-1","volume":"15","author":"A Muscella","year":"2003","unstructured":"Muscella A, Elia MG, Greco S, Storelli C, Marsigliante S (2003) Activation of P2Y2 purinoceptor inhibits the activity of the Na+\/K+-ATPase in HeLa cells. Cell Signal 15(1):115\u2013121. https:\/\/doi.org\/10.1016\/s0898-6568(02)00062-1","journal-title":"Cell Signal"},{"issue":"3","key":"9785_CR82","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/jcp.20033","volume":"200","author":"A Muscella","year":"2004","unstructured":"Muscella A, Greco S, Elia MG, Storelli C, Marsigliante S (2004) Differential signalling of purinoceptors in HeLa cells through the extracellular signal-regulated kinase and protein kinase C pathways. J Cell Physiol 200(3):428\u2013439. https:\/\/doi.org\/10.1002\/jcp.20033","journal-title":"J Cell Physiol"},{"issue":"12","key":"9785_CR83","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","volume":"72","author":"E Adinolfi","year":"2012","unstructured":"Adinolfi E, Raffaghello L, Giuliani AL, Cavazzini L, Capece M, Chiozzi P, Bianchi G, Kroemer G, Pistoia V, Di Virgilio F (2012) Expression of P2X7 receptor increases in vivo tumor growth. Cancer Res 72(12):2957\u20132969. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-1947","journal-title":"Cancer Res"},{"issue":"7","key":"9785_CR84","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1071\/RD12196","volume":"25","author":"FG Vazquez-Cuevas","year":"2013","unstructured":"Vazquez-Cuevas FG, Cruz-Rico A, Garay E, Garcia-Carranca A, Perez-Montiel D, Juarez B, Arellano RO (2013) Differential expression of the P2X7 receptor in ovarian surface epithelium during the oestrous cycle in the mouse. Reprod Fertil Dev 25(7):971\u2013984. https:\/\/doi.org\/10.1071\/RD12196","journal-title":"Reprod Fertil Dev"},{"issue":"5","key":"9785_CR85","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1093\/molehr\/6.5.435","volume":"6","author":"A Schultze-Mosgau","year":"2000","unstructured":"Schultze-Mosgau A, Katzur AC, Arora KK, Stojilkovic SS, Diedrich K, Ortmann O (2000) Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells. Mol Hum Reprod 6(5):435\u2013442","journal-title":"Mol Hum Reprod"},{"issue":"1","key":"9785_CR86","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1095\/biolreprod.102.006551","volume":"68","author":"KC Choi","year":"2003","unstructured":"Choi KC, Tai CJ, Tzeng CR, Auersperg N, Leung PC (2003) Adenosine triphosphate activates mitogen-activated protein kinase in pre-neoplastic and neoplastic ovarian surface epithelial cells. Biol Reprod 68(1):309\u2013315. https:\/\/doi.org\/10.1095\/biolreprod.102.006551","journal-title":"Biol Reprod"},{"issue":"4","key":"9785_CR87","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/jcb.25390","volume":"117","author":"AS Martinez-Ramirez","year":"2016","unstructured":"Martinez-Ramirez AS, Garay E, Garcia-Carranca A, Vazquez-Cuevas FG (2016) The P2RY2 receptor induces carcinoma cell migration and EMT through cross-talk with epidermal growth factor receptor. J Cell Biochem 117(4):1016\u20131026. https:\/\/doi.org\/10.1002\/jcb.25390","journal-title":"J Cell Biochem"},{"issue":"1","key":"9785_CR88","first-page":"43","volume":"10","author":"S Hajiahmadi","year":"2015","unstructured":"Hajiahmadi S, Panjehpour M, Aghaei M, Mousavi S (2015) Molecular expression of adenosine receptors in OVCAR-3, Caov-4 and SKOV-3 human ovarian cancer cell lines. Res Pharm Sci 10(1):43\u201351","journal-title":"Res Pharm Sci"},{"issue":"4","key":"9785_CR89","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1139\/bcb-2014-0117","volume":"93","author":"S Hajiahmadi","year":"2015","unstructured":"Hajiahmadi S, Panjehpour M, Aghaei M, Shabani M (2015) Activation of A2b adenosine receptor regulates ovarian cancer cell growth: involvement of Bax\/Bcl-2 and caspase-3. Biochem Cell Biol 93(4):321\u2013329. https:\/\/doi.org\/10.1139\/bcb-2014-0117","journal-title":"Biochem Cell Biol"},{"issue":"21","key":"9785_CR90","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1158\/0008-5472.CAN-14-3569","volume":"75","author":"M Turcotte","year":"2015","unstructured":"Turcotte M, Spring K, Pommey S, Chouinard G, Cousineau I, George J, Chen GM, Gendoo DM, Haibe-Kains B, Karn T, Rahimi K, Le Page C, Provencher D, Mes-Masson AM, Stagg J (2015) CD73 is associated with poor prognosis in high-grade serous ovarian cancer. Cancer Res 75(21):4494\u20134503. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3569","journal-title":"Cancer Res"},{"issue":"5","key":"9785_CR91","doi-asserted-by":"publisher","first-page":"e1127496","DOI":"10.1080\/2162402X.2015.1127496","volume":"5","author":"PO Gaudreau","year":"2016","unstructured":"Gaudreau PO, Allard B, Turcotte M, Stagg J (2016) CD73-adenosine reduces immune responses and survival in ovarian cancer patients. Oncoimmunology 5(5):e1127496. https:\/\/doi.org\/10.1080\/2162402X.2015.1127496","journal-title":"Oncoimmunology"},{"issue":"10","key":"9785_CR92","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00262-011-1040-4","volume":"60","author":"SF Hausler","year":"2011","unstructured":"Hausler SF, Montalban del Barrio I, Strohschein J, Chandran PA, Engel JB, Honig A, Ossadnik M, Horn E, Fischer B, Krockenberger M, Heuer S, Seida AA, Junker M, Kneitz H, Kloor D, Klotz KN, Dietl J, Wischhusen J (2011) Ectonucleotidases CD39 and CD73 on OvCA cells are potent adenosine-generating enzymes responsible for adenosine receptor 2A-dependent suppression of T cell function and NK cell cytotoxicity. Cancer Immunol Immunother 60(10):1405\u20131418. https:\/\/doi.org\/10.1007\/s00262-011-1040-4","journal-title":"Cancer Immunol Immunother"},{"key":"9785_CR93","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s40425-016-0154-9","volume":"4","author":"I Montalban Del Barrio","year":"2016","unstructured":"Montalban Del Barrio I, Penski C, Schlahsa L, Stein RG, Diessner J, Wockel A, Dietl J, Lutz MB, Mittelbronn M, Wischhusen J, Hausler SFM (2016) Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape. J Immunother Cancer 4:49. https:\/\/doi.org\/10.1186\/s40425-016-0154-9","journal-title":"J Immunother Cancer"},{"issue":"3","key":"9785_CR94","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s11302-019-09675-0","volume":"15","author":"A Asif","year":"2019","unstructured":"Asif A, Khalid M, Manzoor S, Ahmad H, Rehman AU (2019) Role of purinergic receptors in hepatobiliary carcinoma in Pakistani population: an approach towards proinflammatory role of P2X4 and P2X7 receptors. Purinergic Signal 15(3):367\u2013374. https:\/\/doi.org\/10.1007\/s11302-019-09675-0","journal-title":"Purinergic Signal"},{"key":"9785_CR95","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/1743-422X-8-431","volume":"8","author":"S Manzoor","year":"2011","unstructured":"Manzoor S, Idrees M, Ashraf J, Mehmood A, Butt S, Fatima K, Akbar H, Rehaman IU, Qadri I (2011) Identification of ionotrophic purinergic receptors in Huh-7 cells and their response towards structural proteins of HCV genotype 3a. Virol J 8:431. https:\/\/doi.org\/10.1186\/1743-422X-8-431","journal-title":"Virol J"},{"issue":"6","key":"9785_CR96","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s11033-018-4432-0","volume":"45","author":"M Khalid","year":"2018","unstructured":"Khalid M, Manzoor S, Ahmad H, Asif A, Bangash TA, Latif A, Jaleel S (2018) Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor. Mol Biol Rep 45(6):2625\u20132630. https:\/\/doi.org\/10.1007\/s11033-018-4432-0","journal-title":"Mol Biol Rep"},{"issue":"7","key":"9785_CR97","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1007\/s13277-015-3155-2","volume":"36","author":"H Liu","year":"2015","unstructured":"Liu H, Liu W, Liu Z, Liu Y, Zhang W, Xu L, Xu J (2015) Prognostic value of purinergic P2X7 receptor expression in patients with hepatocellular carcinoma after curative resection. Tumour Biol 36(7):5039\u20135049. https:\/\/doi.org\/10.1007\/s13277-015-3155-2","journal-title":"Tumour Biol"},{"key":"9785_CR98","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.12659\/msm.895763","volume":"22","author":"S Duan","year":"2016","unstructured":"Duan S, Yu J, Han Z, Cheng Z, Liang P (2016) Association between P2RX7 gene and hepatocellular carcinoma susceptibility: a case-control study in a Chinese Han population. Med Sci Monit 22:1916\u20131923. https:\/\/doi.org\/10.12659\/msm.895763","journal-title":"Med Sci Monit"},{"issue":"38","key":"9785_CR99","doi-asserted-by":"publisher","first-page":"41162","DOI":"10.18632\/oncotarget.6240","volume":"6","author":"JP Maynard","year":"2015","unstructured":"Maynard JP, Lee JS, Sohn BH, Yu X, Lopez-Terrada D, Finegold MJ, Goss JA, Thevananther S (2015) P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients. Oncotarget 6(38):41162\u201341179. https:\/\/doi.org\/10.18632\/oncotarget.6240","journal-title":"Oncotarget"},{"issue":"27","key":"9785_CR100","doi-asserted-by":"publisher","first-page":"19137","DOI":"10.1074\/jbc.M113.540047","volume":"289","author":"R Xie","year":"2014","unstructured":"Xie R, Xu J, Wen G, Jin H, Liu X, Yang Y, Ji B, Jiang Y, Song P, Dong H, Tuo B (2014) The P2Y2 nucleotide receptor mediates the proliferation and migration of human hepatocellular carcinoma cells induced by ATP. J Biol Chem 289(27):19137\u201319149. https:\/\/doi.org\/10.1074\/jbc.M113.540047","journal-title":"J Biol Chem"},{"issue":"4","key":"9785_CR101","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1158\/0008-5472.CAN-19-1909","volume":"80","author":"I Schulien","year":"2020","unstructured":"Schulien I, Hockenjos B, van Marck V, Ayata CK, Follo M, Thimme R, Hasselblatt P (2020) Extracellular ATP and purinergic P2Y2 receptor signaling promote liver tumorigenesis in mice by exacerbating DNA damage. Cancer Res 80(4):699\u2013708. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1909","journal-title":"Cancer Res"},{"issue":"23","key":"9785_CR102","doi-asserted-by":"publisher","first-page":"37278","DOI":"10.18632\/oncotarget.16191","volume":"8","author":"M Khalid","year":"2017","unstructured":"Khalid M, Brisson L, Tariq M, Hao Y, Guibon R, Fromont G, Mortadza SAS, Mousawi F, Manzoor S, Roger S, Jiang LH (2017) Carcinoma-specific expression of P2Y11 receptor and its contribution in ATP-induced purinergic signalling and cell migration in human hepatocellular carcinoma cells. Oncotarget 8(23):37278\u201337290. https:\/\/doi.org\/10.18632\/oncotarget.16191","journal-title":"Oncotarget"},{"issue":"7","key":"9785_CR103","doi-asserted-by":"publisher","first-page":"10248","DOI":"10.1002\/jcp.27694","volume":"234","author":"S Shali","year":"2019","unstructured":"Shali S, Yu J, Zhang X, Wang X, Jin Y, Su M, Liao X, Yu J, Zhi X, Zhou P (2019) Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma. J Cell Physiol 234(7):10248\u201310259. https:\/\/doi.org\/10.1002\/jcp.27694","journal-title":"J Cell Physiol"},{"issue":"1","key":"9785_CR104","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13045-019-0724-7","volume":"12","author":"XL Ma","year":"2019","unstructured":"Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, Yang XR, Guo W (2019) CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K\/AKT signaling by inducing Rap1-mediated membrane localization of P110beta and predicts poor prognosis. J Hematol Oncol 12(1):37. https:\/\/doi.org\/10.1186\/s13045-019-0724-7","journal-title":"J Hematol Oncol"},{"issue":"2","key":"9785_CR105","first-page":"287","volume":"33","author":"S Bar-Yehuda","year":"2008","unstructured":"Bar-Yehuda S, Stemmer SM, Madi L, Castel D, Ochaion A, Cohen S, Barer F, Zabutti A, Perez-Liz G, Del Valle L, Fishman P (2008) The A3 adenosine receptor agonist CF102 induces apoptosis of hepatocellular carcinoma via de-regulation of the Wnt and NF-kappaB signal transduction pathways. Int J Oncol 33(2):287\u2013295","journal-title":"Int J Oncol"},{"issue":"5","key":"9785_CR106","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.7314\/APJCP.2014.15.5.1931","volume":"15","author":"G Aquea","year":"2014","unstructured":"Aquea G, Bresky G, Lancellotti D, Madariaga JA, Zaffiri V, Urzua U, Haberle S, Bernal G (2014) Increased expression of P2RY2, CD248 and EphB1 in gastric cancers from Chilean patients. Asian Pac J Cancer Prev 15(5):1931\u20131936","journal-title":"Asian Pac J Cancer Prev"},{"key":"9785_CR107","doi-asserted-by":"publisher","unstructured":"Hevia MJ, Castro P, Pinto-Irish K, Reyna-Jeldes M, Rodr\u00edguez-Tirado F, Robles-Planells C, Ram\u00edrez-Rivera S, Madariaga JA, Guti\u00e9rrez F, L\u00f3pez J, Barra M, De La Fuente-Ortega E, Bernal G, Coddou C (2019) Differential effects of purinergic signaling in gastric cancer derived cells through P2Y and P2X receptors. Frontiers in Pharmacology in press. https:\/\/doi.org\/10.3389\/fphar.2019.00612","DOI":"10.3389\/fphar.2019.00612"},{"issue":"1","key":"9785_CR108","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1038\/s41598-017-02562-x","volume":"7","author":"H Wan","year":"2017","unstructured":"Wan H, Xie R, Xu J, He J, Tang B, Liu Q, Wang S, Guo Y, Yang X, Dong TX, Carethers JM, Yang S, Dong H (2017) Anti-proliferative Effects of Nucleotides on Gastric Cancer via a Novel P2Y6\/SOCE\/Ca(2+)\/beta-catenin Pathway. Sci Rep 7(1):2459. https:\/\/doi.org\/10.1038\/s41598-017-02562-x","journal-title":"Sci Rep"},{"issue":"9","key":"9785_CR109","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1535370219846492","volume":"244","author":"W Lili","year":"2019","unstructured":"Lili W, Yun L, Tingran W, Xia W, Yanlei S (2019) P2RX7 functions as a putative biomarker of gastric cancer and contributes to worse prognosis. Exp Biol Med (Maywood) 244(9):734\u2013742. https:\/\/doi.org\/10.1177\/1535370219846492","journal-title":"Exp Biol Med (Maywood)"},{"issue":"10","key":"9785_CR110","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.bcp.2004.01.020","volume":"67","author":"M Saitoh","year":"2004","unstructured":"Saitoh M, Nagai K, Nakagawa K, Yamamura T, Yamamoto S, Nishizaki T (2004) Adenosine induces apoptosis in the human gastric cancer cells via an intrinsic pathway relevant to activation of AMP-activated protein kinase. Biochem Pharmacol 67(10):2005\u20132011. https:\/\/doi.org\/10.1016\/j.bcp.2004.01.020","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"9785_CR111","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1745-7254.2006.00342.x","volume":"27","author":"MX Wang","year":"2006","unstructured":"Wang MX, Ren LM (2006) Growth inhibitory effect and apoptosis induced by extracellular ATP and adenosine on human gastric carcinoma cells: involvement of intracellular uptake of adenosine. Acta Pharmacol Sin 27(8):1085\u20131092. https:\/\/doi.org\/10.1111\/j.1745-7254.2006.00342.x","journal-title":"Acta Pharmacol Sin"},{"issue":"19","key":"9785_CR112","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1091\/mbc.E19-03-0136","volume":"30","author":"L Shi","year":"2019","unstructured":"Shi L, Wu Z, Miao J, Du S, Ai S, Xu E, Feng M, Song J, Guan W (2019) Adenosine interaction with adenosine receptor A2a promotes gastric cancer metastasis by enhancing PI3K-AKT-mTOR signaling. Mol Biol Cell 30(19):2527\u20132534. https:\/\/doi.org\/10.1091\/mbc.E19-03-0136","journal-title":"Mol Biol Cell"},{"issue":"4","key":"9785_CR113","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/sj.bjc.6600100","volume":"86","author":"K Maaser","year":"2002","unstructured":"Maaser K, Hopfner M, Kap H, Sutter AP, Barthel B, von Lampe B, Zeitz M, Scherubl H (2002) Extracellular nucleotides inhibit growth of human oesophageal cancer cells via P2Y(2)-receptors. Br J Cancer 86(4):636\u2013644. https:\/\/doi.org\/10.1038\/sj.bjc.6600100","journal-title":"Br J Cancer"},{"issue":"3","key":"9785_CR114","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s11302-017-9559-2","volume":"13","author":"AA Santos Jr","year":"2017","unstructured":"Santos AA Jr, Cappellari AR, de Marchi FO, Gehring MP, Zaparte A, Brandao CA, Lopes TG, da Silva VD, Pinto LFR, Savio LEB, Moreira-Souza ACA, Coutinho-Silva R, Paccez JD, Zerbini LF, Morrone FB (2017) Potential role of P2X7R in esophageal squamous cell carcinoma proliferation. Purinergic Signal 13(3):279\u2013292. https:\/\/doi.org\/10.1007\/s11302-017-9559-2","journal-title":"Purinergic Signal"},{"issue":"3","key":"9785_CR115","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s003840100302","volume":"16","author":"M Hopfner","year":"2001","unstructured":"Hopfner M, Maaser K, Barthel B, von Lampe B, Hanski C, Riecken EO, Zeitz M, Scherubl H (2001) Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int J Color Dis 16(3):154\u2013166. https:\/\/doi.org\/10.1007\/s003840100302","journal-title":"Int J Color Dis"},{"issue":"2","key":"9785_CR116","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1474-8673.2007.00389.x","volume":"27","author":"G Nylund","year":"2007","unstructured":"Nylund G, Hultman L, Nordgren S, Delbro DS (2007) P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer. Auton Autacoid Pharmacol 27(2):79\u201384. https:\/\/doi.org\/10.1111\/j.1474-8673.2007.00389.x","journal-title":"Auton Autacoid Pharmacol"},{"issue":"8","key":"9785_CR117","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.biochi.2012.04.006","volume":"94","author":"Y Limami","year":"2012","unstructured":"Limami Y, Pinon A, Leger DY, Pinault E, Delage C, Beneytout JL, Simon A, Liagre B (2012) The P2Y2\/Src\/p38\/COX-2 pathway is involved in the resistance to ursolic acid-induced apoptosis in colorectal and prostate cancer cells. Biochimie 94(8):1754\u20131763. https:\/\/doi.org\/10.1016\/j.biochi.2012.04.006","journal-title":"Biochimie"},{"issue":"5 Pt A","key":"9785_CR118","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.bbadis.2018.02.008","volume":"1864","author":"M Placet","year":"2018","unstructured":"Placet M, Arguin G, Molle CM, Babeu JP, Jones C, Carrier JC, Robaye B, Geha S, Boudreau F, Gendron FP (2018) The G protein-coupled P2Y(6) receptor promotes colorectal cancer tumorigenesis by inhibiting apoptosis. Biochim Biophys Acta Mol basis Dis 1864(5 Pt A):1539\u20131551. https:\/\/doi.org\/10.1016\/j.bbadis.2018.02.008","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"key":"9785_CR119","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.humpath.2017.03.019","volume":"64","author":"F Qian","year":"2017","unstructured":"Qian F, Xiao J, Hu B, Sun N, Yin W, Zhu J (2017) High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer. Hum Pathol 64:61\u201368. https:\/\/doi.org\/10.1016\/j.humpath.2017.03.019","journal-title":"Hum Pathol"},{"issue":"2","key":"9785_CR120","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.advms.2019.05.002","volume":"64","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Ding J, Wang L (2019) The role of P2X7 receptor in prognosis and metastasis of colorectal cancer. Adv Med Sci 64(2):388\u2013394. https:\/\/doi.org\/10.1016\/j.advms.2019.05.002","journal-title":"Adv Med Sci"},{"issue":"8","key":"9785_CR121","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1038\/sj.bjc.6601315","volume":"89","author":"G Ohana","year":"2003","unstructured":"Ohana G, Bar-Yehuda S, Arich A, Madi L, Dreznick Z, Rath-Wolfson L, Silberman D, Slosman G, Fishman P (2003) Inhibition of primary colon carcinoma growth and liver metastasis by the A3 adenosine receptor agonist CF101. Br J Cancer 89(8):1552\u20131558. https:\/\/doi.org\/10.1038\/sj.bjc.6601315","journal-title":"Br J Cancer"},{"issue":"1-2","key":"9785_CR122","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.abb.2013.02.007","volume":"533","author":"M Sakowicz-Burkiewicz","year":"2013","unstructured":"Sakowicz-Burkiewicz M, Kitowska A, Grden M, Maciejewska I, Szutowicz A, Pawelczyk T (2013) Differential effect of adenosine receptors on growth of human colon cancer HCT 116 and HT-29 cell lines. Arch Biochem Biophys 533(1-2):47\u201354. https:\/\/doi.org\/10.1016\/j.abb.2013.02.007","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"9785_CR123","doi-asserted-by":"publisher","first-page":"G223","DOI":"10.1152\/ajpgi.00259.2006","volume":"292","author":"BM Kunzli","year":"2007","unstructured":"Kunzli BM, Berberat PO, Giese T, Csizmadia E, Kaczmarek E, Baker C, Halaceli I, Buchler MW, Friess H, Robson SC (2007) Upregulation of CD39\/NTPDases and P2 receptors in human pancreatic disease. Am J Physiol Gastrointest Liver Physiol 292(1):G223\u2013G230. https:\/\/doi.org\/10.1152\/ajpgi.00259.2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"9785_CR124","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/MPA.0b013e318271bb4b","volume":"42","author":"JH Choi","year":"2013","unstructured":"Choi JH, Ji YG, Lee DH (2013) Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor. Pancreas 42(4):680\u2013686. https:\/\/doi.org\/10.1097\/MPA.0b013e318271bb4b","journal-title":"Pancreas"},{"issue":"4","key":"9785_CR125","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-18-2297","volume":"25","author":"LP Hu","year":"2019","unstructured":"Hu LP, Zhang XX, Jiang SH, Tao LY, Li Q, Zhu LL, Yang MW, Huo YM, Jiang YS, Tian GA, Cao XY, Zhang YL, Yang Q, Yang XM, Wang YH, Li J, Xiao GG, Sun YW, Zhang ZG (2019) Targeting purinergic receptor P2Y2 prevents the growth of pancreatic ductal adenocarcinoma by inhibiting cancer cell glycolysis. Clin Cancer Res 25(4):1318\u20131330. https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-2297","journal-title":"Clin Cancer Res"},{"issue":"12","key":"9785_CR126","doi-asserted-by":"publisher","first-page":"e51164","DOI":"10.1371\/journal.pone.0051164","volume":"7","author":"KA Haanes","year":"2012","unstructured":"Haanes KA, Schwab A, Novak I (2012) The P2X7 receptor supports both life and death in fibrogenic pancreatic stellate cells. PLoS One 7(12):e51164. https:\/\/doi.org\/10.1371\/journal.pone.0051164","journal-title":"PLoS One"},{"issue":"11","key":"9785_CR127","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1002\/ijc.30380","volume":"139","author":"A Giannuzzo","year":"2016","unstructured":"Giannuzzo A, Saccomano M, Napp J, Ellegaard M, Alves F, Novak I (2016) Targeting of the P2X7 receptor in pancreatic cancer and stellate cells. Int J Cancer 139(11):2540\u20132552. https:\/\/doi.org\/10.1002\/ijc.30380","journal-title":"Int J Cancer"},{"issue":"58","key":"9785_CR128","doi-asserted-by":"publisher","first-page":"97822","DOI":"10.18632\/oncotarget.22085","volume":"8","author":"A Mohammed","year":"2017","unstructured":"Mohammed A, Janakiram NB, Madka V, Pathuri G, Li Q, Ritchie R, Biddick L, Kutche H, Zhang Y, Singh A, Gali H, Lightfoot S, Steele VE, Suen CS, Rao CV (2017) Lack of chemopreventive effects of P2X7R inhibitors against pancreatic cancer. Oncotarget 8(58):97822\u201397834. https:\/\/doi.org\/10.18632\/oncotarget.22085","journal-title":"Oncotarget"},{"issue":"10066","key":"9785_CR129","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0140-6736(16)30958-8","volume":"389","author":"FR Hirsch","year":"2017","unstructured":"Hirsch FR, Scagliotti GV, Mulshine JL, Kwon R, Curran WJ Jr, Wu YL, Paz-Ares L (2017) Lung cancer: current therapies and new targeted treatments. Lancet 389(10066):299\u2013311. https:\/\/doi.org\/10.1016\/S0140-6736(16)30958-8","journal-title":"Lancet"},{"issue":"2","key":"9785_CR130","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11302-007-9059-x","volume":"4","author":"S Tatur","year":"2008","unstructured":"Tatur S, Kreda S, Lazarowski E, Grygorczyk R (2008) Calcium-dependent release of adenosine and uridine nucleotides from A549 cells. Purinergic Signal 4(2):139\u2013146. https:\/\/doi.org\/10.1007\/s11302-007-9059-x","journal-title":"Purinergic Signal"},{"issue":"8","key":"9785_CR131","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1097\/00001813-200309000-00009","volume":"14","author":"HJ Agteresch","year":"2003","unstructured":"Agteresch HJ, Burgers SA, van der Gaast A, Wilson JH, Dagnelie PC (2003) Randomized clinical trial of adenosine 5'-triphosphate on tumor growth and survival in advanced lung cancer patients. Anti-Cancer Drugs 14(8):639\u2013644. https:\/\/doi.org\/10.1097\/00001813-200309000-00009","journal-title":"Anti-Cancer Drugs"},{"issue":"1A","key":"9785_CR132","first-page":"43","volume":"26","author":"K Nakamura","year":"2006","unstructured":"Nakamura K, Yoshikawa N, Yamaguchi Y, Kagota S, Shinozuka K, Kunitomo M (2006) Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res 26(1A):43\u201347","journal-title":"Anticancer Res"},{"issue":"2","key":"9785_CR133","first-page":"188","volume":"49","author":"WG Fang","year":"2017","unstructured":"Fang WG, Tian XX (2017) Identification of a new pro-invasion factor in tumor microenvironment: progress in function and mechanism of extracellular ATP. Beijing Da Xue Xue Bao 49(2):188\u2013195","journal-title":"Beijing Da Xue Xue Bao"},{"issue":"35","key":"9785_CR134","doi-asserted-by":"publisher","first-page":"26792","DOI":"10.1074\/jbc.M002770200","volume":"275","author":"BD Humphreys","year":"2000","unstructured":"Humphreys BD, Rice J, Kertesy SB, Dubyak GR (2000) Stress-activated protein kinase\/JNK activation and apoptotic induction by the macrophage P2X7 nucleotide receptor. J Biol Chem 275(35):26792\u201326798. https:\/\/doi.org\/10.1074\/jbc.M002770200","journal-title":"J Biol Chem"},{"key":"9785_CR135","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/bs.apcsb.2015.11.004","volume":"104","author":"E De Marchi","year":"2016","unstructured":"De Marchi E, Orioli E, Dal Ben D, Adinolfi E (2016) P2X7 receptor as a therapeutic target. Adv Protein Chem Struct Biol 104:39\u201379. https:\/\/doi.org\/10.1016\/bs.apcsb.2015.11.004","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"16","key":"9785_CR136","doi-asserted-by":"publisher","first-page":"7410","DOI":"10.1021\/acs.jmedchem.5b01690","volume":"59","author":"JH Park","year":"2016","unstructured":"Park JH, Williams DR, Lee JH, Lee SD, Lee JH, Ko H, Lee GE, Kim S, Lee JM, Abdelrahman A, Muller CE, Jung DW, Kim YC (2016) Potent suppressive effects of 1-piperidinylimidazole based novel P2X7 receptor antagonists on cancer cell migration and invasion. J Med Chem 59(16):7410\u20137430. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b01690","journal-title":"J Med Chem"},{"issue":"1","key":"9785_CR137","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3892\/ol.2014.2620","volume":"9","author":"L Boldrini","year":"2015","unstructured":"Boldrini L, Giordano M, Ali G, Melfi F, Romano G, Lucchi M, Fontanini G (2015) P2X7 mRNA expression in non-small cell lung cancer: MicroRNA regulation and prognostic value. Oncol Lett 9(1):449\u2013453. https:\/\/doi.org\/10.3892\/ol.2014.2620","journal-title":"Oncol Lett"},{"key":"9785_CR138","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1477-5751-13-16","volume":"13","author":"L Boldrini","year":"2014","unstructured":"Boldrini L, Giordano M, Ali G, Servadio A, Pelliccioni S, Niccoli C, Mussi A, Fontanini G (2014) P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). J Negat Results Biomed 13:16. https:\/\/doi.org\/10.1186\/1477-5751-13-16","journal-title":"J Negat Results Biomed"},{"issue":"7","key":"9785_CR139","doi-asserted-by":"publisher","first-page":"e14445","DOI":"10.1097\/MD.0000000000014445","volume":"98","author":"J Ma","year":"2019","unstructured":"Ma J, Li W, Chai Q, Tan X, Zhang K (2019) Correlation of P2RX7 gene rs1718125 polymorphism with postoperative fentanyl analgesia in patients with lung cancer. Medicine (Baltimore) 98(7):e14445. https:\/\/doi.org\/10.1097\/MD.0000000000014445","journal-title":"Medicine (Baltimore)"},{"issue":"24","key":"9785_CR140","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.7150\/thno.48229","volume":"10","author":"J Benzaquen","year":"2020","unstructured":"Benzaquen J, Dit Hreich SJ, Heeke S, Juhel T, Lalvee S, Bauwens S, Saccani S, Lenormand P, Hofman V, Butori M, Leroy S, Berthet JP, Marquette CH, Hofman P, Vouret-Craviari V (2020) P2RX7B is a new theranostic marker for lung adenocarcinoma patients. Theranostics 10(24):10849\u201310860. https:\/\/doi.org\/10.7150\/thno.48229","journal-title":"Theranostics"},{"issue":"1","key":"9785_CR141","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41467-021-20912-2","volume":"12","author":"L Douguet","year":"2021","unstructured":"Douguet L, Janho Dit Hreich S, Benzaquen J, Seguin L, Juhel T, Dezitter X, Duranton C, Ryffel B, Kanellopoulos J, Delarasse C, Renault N, Furman C, Homerin G, Feral C, Cherfils-Vicini J, Millet R, Adriouch S, Ghinet A, Hofman P, Vouret-Craviari V (2021) A small-molecule P2RX7 activator promotes anti-tumor immune responses and sensitizes lung tumor to immunotherapy. Nat Commun 12(1):653. https:\/\/doi.org\/10.1038\/s41467-021-20912-2","journal-title":"Nat Commun"},{"issue":"3","key":"9785_CR142","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/path.4847","volume":"241","author":"YJ Heng","year":"2017","unstructured":"Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH (2017) The molecular basis of breast cancer pathological phenotypes. J Pathol 241(3):375\u2013391. https:\/\/doi.org\/10.1002\/path.4847","journal-title":"J Pathol"},{"issue":"2","key":"9785_CR143","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pathol.2016.10.012","volume":"49","author":"EA Rakha","year":"2017","unstructured":"Rakha EA, Green AR (2017) Molecular classification of breast cancer: what the pathologist needs to know. Pathology 49(2):111\u2013119. https:\/\/doi.org\/10.1016\/j.pathol.2016.10.012","journal-title":"Pathology"},{"issue":"10","key":"9785_CR144","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1200\/JCO.2009.24.9284","volume":"28","author":"KD Voduc","year":"2010","unstructured":"Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28(10):1684\u20131691. https:\/\/doi.org\/10.1200\/JCO.2009.24.9284","journal-title":"J Clin Oncol"},{"issue":"9","key":"9785_CR145","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/nm1622","volume":"13","author":"L Apetoh","year":"2007","unstructured":"Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, Yang H, Amigorena S, Ryffel B, Barrat FJ, Saftig P, Levi F, Lidereau R, Nogues C, Mira JP, Chompret A, Joulin V, Clavel-Chapelon F, Bourhis J, Andre F, Delaloge S, Tursz T, Kroemer G, Zitvogel L (2007) Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 13(9):1050\u20131059. https:\/\/doi.org\/10.1038\/nm1622","journal-title":"Nat Med"},{"issue":"19","key":"9785_CR146","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.1038\/s41388-019-0684-y","volume":"38","author":"E De Marchi","year":"2019","unstructured":"De Marchi E, Orioli E, Pegoraro A, Sangaletti S, Portararo P, Curti A, Colombo MP, Di Virgilio F, Adinolfi E (2019) The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment. Oncogene 38(19):3636\u20133650. https:\/\/doi.org\/10.1038\/s41388-019-0684-y","journal-title":"Oncogene"},{"key":"9785_CR147","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3389\/fimmu.2017.01918","volume":"8","author":"M Lecciso","year":"2017","unstructured":"Lecciso M, Ocadlikova D, Sangaletti S, Trabanelli S, De Marchi E, Orioli E, Pegoraro A, Portararo P, Jandus C, Bontadini A, Redavid A, Salvestrini V, Romero P, Colombo MP, Di Virgilio F, Cavo M, Adinolfi E, Curti A (2017) ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells. Front Immunol 8:1918. https:\/\/doi.org\/10.3389\/fimmu.2017.01918","journal-title":"Front Immunol"},{"issue":"41","key":"9785_CR148","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/onc.2014.444","volume":"34","author":"F Amoroso","year":"2015","unstructured":"Amoroso F, Capece M, Rotondo A, Cangelosi D, Ferracin M, Franceschini A, Raffaghello L, Pistoia V, Varesio L, Adinolfi E (2015) The P2X7 receptor is a key modulator of the PI3K\/GSK3beta\/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 34(41):5240\u20135251. https:\/\/doi.org\/10.1038\/onc.2014.444","journal-title":"Oncogene"},{"issue":"5","key":"9785_CR149","doi-asserted-by":"publisher","first-page":"R77","DOI":"10.1186\/bcr3694","volume":"16","author":"H Jin","year":"2014","unstructured":"Jin H, Eun SY, Lee JS, Park SW, Lee JH, Chang KC, Kim HJ (2014) P2Y2 receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells. Breast Cancer Res 16(5):R77. https:\/\/doi.org\/10.1186\/bcr3694","journal-title":"Breast Cancer Res"},{"key":"9785_CR150","doi-asserted-by":"publisher","unstructured":"Jin H, Kim HJ (2020) NLRC4, ASC and caspase-1 are inflammasome components that are mediated by P2Y2R activation in breast cancer cells. Int J Mol Sci 21(9). https:\/\/doi.org\/10.3390\/ijms21093337","DOI":"10.3390\/ijms21093337"},{"key":"9785_CR151","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.coph.2016.04.001","volume":"29","author":"B Allard","year":"2016","unstructured":"Allard B, Beavis PA, Darcy PK, Stagg J (2016) Immunosuppressive activities of adenosine in cancer. Curr Opin Pharmacol 29:7\u201316. https:\/\/doi.org\/10.1016\/j.coph.2016.04.001","journal-title":"Curr Opin Pharmacol"},{"key":"9785_CR152","doi-asserted-by":"publisher","unstructured":"Campos-Contreras ADR, Diaz-Munoz M, Vazquez-Cuevas FG (2020) Purinergic signaling in the hallmarks of cancer. Cells 9(7). https:\/\/doi.org\/10.3390\/cells9071612","DOI":"10.3390\/cells9071612"},{"issue":"2","key":"9785_CR153","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/sj.bjp.0706180","volume":"145","author":"M Panjehpour","year":"2005","unstructured":"Panjehpour M, Castro M, Klotz KN (2005) Human breast cancer cell line MDA-MB-231 expresses endogenous A2B adenosine receptors mediating a Ca2+ signal. Br J Pharmacol 145(2):211\u2013218. https:\/\/doi.org\/10.1038\/sj.bjp.0706180","journal-title":"Br J Pharmacol"},{"issue":"8","key":"9785_CR154","doi-asserted-by":"publisher","first-page":"e0202914","DOI":"10.1371\/journal.pone.0202914","volume":"13","author":"M Koussemou","year":"2018","unstructured":"Koussemou M, Lorenz K, Klotz KN (2018) The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1\/2 phosphorylation by activation of MAPK-phosphatase-1. PLoS One 13(8):e0202914. https:\/\/doi.org\/10.1371\/journal.pone.0202914","journal-title":"PLoS One"},{"issue":"1","key":"9785_CR155","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4049\/jimmunol.1101845","volume":"188","author":"C Cekic","year":"2012","unstructured":"Cekic C, Sag D, Li Y, Theodorescu D, Strieter RM, Linden J (2012) Adenosine A2B receptor blockade slows growth of bladder and breast tumors. J Immunol 188(1):198\u2013205. https:\/\/doi.org\/10.4049\/jimmunol.1101845","journal-title":"J Immunol"},{"issue":"3","key":"9785_CR156","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1158\/2326-6066.CIR-19-0749","volume":"8","author":"J Yan","year":"2020","unstructured":"Yan J, Li XY, Roman Aguilera A, Xiao C, Jacoberger-Foissac C, Nowlan B, Robson SC, Beers C, Moesta AK, Geetha N, Teng MWL, Smyth MJ (2020) Control of metastases via myeloid CD39 and NK cell effector function. Cancer Immunol Res 8(3):356\u2013367. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0749","journal-title":"Cancer Immunol Res"},{"issue":"12","key":"9785_CR157","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1158\/2159-8290.CD-19-0541","volume":"9","author":"XY Li","year":"2019","unstructured":"Li XY, Moesta AK, Xiao C, Nakamura K, Casey M, Zhang H, Madore J, Lepletier A, Aguilera AR, Sundarrajan A, Jacoberger-Foissac C, Wong C, Dela Cruz T, Welch M, Lerner AG, Spatola BN, Soros VB, Corbin J, Anderson AC, Effern M, Holzel M, Robson SC, Johnston RL, Waddell N, Smith C, Bald T, Geetha N, Beers C, Teng MWL, Smyth MJ (2019) Targeting CD39 in cancer reveals an extracellular ATP- and inflammasome-driven tumor immunity. Cancer Discov 9(12):1754\u20131773. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-0541","journal-title":"Cancer Discov"},{"issue":"20","key":"9785_CR158","doi-asserted-by":"publisher","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","volume":"19","author":"B Allard","year":"2013","unstructured":"Allard B, Pommey S, Smyth MJ, Stagg J (2013) Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs. Clin Cancer Res 19(20):5626\u20135635. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-0545","journal-title":"Clin Cancer Res"},{"issue":"10","key":"9785_CR159","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1002\/jcp.26743","volume":"233","author":"G Ghalamfarsa","year":"2018","unstructured":"Ghalamfarsa G, Rastegari A, Atyabi F, Hassannia H, Hojjat-Farsangi M, Ghanbari A, Anvari E, Mohammadi J, Azizi G, Masjedi A, Yousefi M, Yousefi B, Hadjati J, Jadidi-Niaragh F (2018) Anti-angiogenic effects of CD73-specific siRNA-loaded nanoparticles in breast cancer-bearing mice. J Cell Physiol 233(10):7165\u20137177. https:\/\/doi.org\/10.1002\/jcp.26743","journal-title":"J Cell Physiol"},{"issue":"5","key":"9785_CR160","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ijc.31112","volume":"142","author":"J Yu","year":"2018","unstructured":"Yu J, Wang X, Lu Q, Wang J, Li L, Liao X, Zhu W, Lv L, Zhi X, Yu J, Jin Y, Zou Q, Ou Z, Liu X, Zhou P (2018) Extracellular 5'-nucleotidase (CD73) promotes human breast cancer cells growth through AKT\/GSK-3beta\/beta-catenin\/cyclinD1 signaling pathway. Int J Cancer 142(5):959\u2013967. https:\/\/doi.org\/10.1002\/ijc.31112","journal-title":"Int J Cancer"},{"issue":"4","key":"9785_CR161","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/annonc\/mdx730","volume":"29","author":"L Buisseret","year":"2018","unstructured":"Buisseret L, Pommey S, Allard B, Garaud S, Bergeron M, Cousineau I, Ameye L, Bareche Y, Paesmans M, Crown JPA, Di Leo A, Loi S, Piccart-Gebhart M, Willard-Gallo K, Sotiriou C, Stagg J (2018) Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial. Ann Oncol 29(4):1056\u20131062. https:\/\/doi.org\/10.1093\/annonc\/mdx730","journal-title":"Ann Oncol"},{"key":"9785_CR162","doi-asserted-by":"publisher","unstructured":"de Araujo JB, Kerkhoff VV, de Oliveira Maciel SFV, de Resende ESDT (2021) Targeting the purinergic pathway in breast cancer and its therapeutic applications. Purinergic Signal. https:\/\/doi.org\/10.1007\/s11302-020-09760-9","DOI":"10.1007\/s11302-020-09760-9"},{"issue":"1","key":"9785_CR163","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13148-020-00904-7","volume":"12","author":"JR Raut","year":"2020","unstructured":"Raut JR, Guan Z, Schrotz-King P, Brenner H (2020) Fecal DNA methylation markers for detecting stages of colorectal cancer and its precursors: a systematic review. Clin Epigenetics 12(1):122. https:\/\/doi.org\/10.1186\/s13148-020-00904-7","journal-title":"Clin Epigenetics"},{"issue":"1","key":"9785_CR164","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11302-013-9397-9","volume":"10","author":"G Burnstock","year":"2014","unstructured":"Burnstock G (2014) Purinergic signalling in the gastrointestinal tract and related organs in health and disease. Purinergic Signal 10(1):3\u201350. https:\/\/doi.org\/10.1007\/s11302-013-9397-9","journal-title":"Purinergic Signal"},{"issue":"19","key":"9785_CR165","doi-asserted-by":"publisher","first-page":"28736","DOI":"10.18632\/oncotarget.7518","volume":"7","author":"HX Wan","year":"2016","unstructured":"Wan HX, Hu JH, Xie R, Yang SM, Dong H (2016) Important roles of P2Y receptors in the inflammation and cancer of digestive system. Oncotarget 7(19):28736\u201328747. https:\/\/doi.org\/10.18632\/oncotarget.7518","journal-title":"Oncotarget"},{"key":"9785_CR166","doi-asserted-by":"publisher","unstructured":"Zhang WLC, Huang C, Pu F, Zhu J, Zhu Z (2021) PI3K\/Akt\/GSK-3\u03b2 signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells. Eur J Pharmacol:174041. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174041","DOI":"10.1016\/j.ejphar.2021.174041"},{"issue":"4","key":"9785_CR167","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s11302-019-09680-3","volume":"15","author":"E Velazquez-Miranda","year":"2019","unstructured":"Velazquez-Miranda E, Diaz-Munoz M, Vazquez-Cuevas FG (2019) Purinergic signaling in hepatic disease. Purinergic Signal 15(4):477\u2013489. https:\/\/doi.org\/10.1007\/s11302-019-09680-3","journal-title":"Purinergic Signal"},{"issue":"2","key":"9785_CR168","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-5793(86)80809-2","volume":"204","author":"DA Horstman","year":"1986","unstructured":"Horstman DA, Tennes KA, Putney JW Jr (1986) ATP-induced calcium mobilization and inositol 1,4,5-triphosphate formation in H-35 hepatoma cells. FEBS Lett 204(2):189\u2013192. https:\/\/doi.org\/10.1016\/0014-5793(86)80809-2","journal-title":"FEBS Lett"},{"issue":"2","key":"9785_CR169","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/hep.22035","volume":"47","author":"DS Emmett","year":"2008","unstructured":"Emmett DS, Feranchak A, Kilic G, Puljak L, Miller B, Dolovcak S, McWilliams R, Doctor RB, Fitz JG (2008) Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology 47(2):698\u2013705. https:\/\/doi.org\/10.1002\/hep.22035","journal-title":"Hepatology"},{"issue":"5","key":"9785_CR170","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386. https:\/\/doi.org\/10.1002\/ijc.29210","journal-title":"Int J Cancer"},{"key":"9785_CR171","doi-asserted-by":"publisher","first-page":"308574","DOI":"10.1155\/2015\/308574","volume":"2015","author":"VV Subhash","year":"2015","unstructured":"Subhash VV, Yeo MS, Tan WL, Yong WP (2015) Strategies and advancements in harnessing the immune system for gastric cancer immunotherapy. J Immunol Res 2015:308574. https:\/\/doi.org\/10.1155\/2015\/308574","journal-title":"J Immunol Res"},{"issue":"7","key":"9785_CR172","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.ejca.2014.01.029","volume":"50","author":"A Ferro","year":"2014","unstructured":"Ferro A, Peleteiro B, Malvezzi M, Bosetti C, Bertuccio P, Levi F, Negri E, La Vecchia C, Lunet N (2014) Worldwide trends in gastric cancer mortality (1980-2011), with predictions to 2015, and incidence by subtype. Eur J Cancer 50(7):1330\u20131344. https:\/\/doi.org\/10.1016\/j.ejca.2014.01.029","journal-title":"Eur J Cancer"},{"issue":"10251","key":"9785_CR173","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet 396(10251):635\u2013648. https:\/\/doi.org\/10.1016\/S0140-6736(20)31288-5","journal-title":"Lancet"},{"issue":"7","key":"9785_CR174","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/iub.1171","volume":"65","author":"W Yuan","year":"2013","unstructured":"Yuan W, Wang Z, Li J, Li D, Liu D, Bai G, Walsh MP, Gui Y, Zheng XL (2013) Uridine adenosine tetraphosphate induces contraction of circular and longitudinal gastric smooth muscle by distinct signaling pathways. IUBMB Life 65(7):623\u2013632. https:\/\/doi.org\/10.1002\/iub.1171","journal-title":"IUBMB Life"},{"issue":"6","key":"9785_CR175","first-page":"407","volume":"31","author":"SC Ahn","year":"1995","unstructured":"Ahn SC, Xu WX, So I, Kim KW, Kang TM (1995) Effects of purinergic agonists on mechanical and electrical activities of gastric smooth muscle of guinea-pig. J Smooth Muscle Res 31(6):407\u2013410","journal-title":"J Smooth Muscle Res"},{"issue":"1","key":"9785_CR176","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","volume":"70","author":"PA Humphrey","year":"2016","unstructured":"Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol 70(1):106\u2013119. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.028","journal-title":"Eur Urol"},{"issue":"1","key":"9785_CR177","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1172\/JCI115562","volume":"89","author":"WG Fang","year":"1992","unstructured":"Fang WG, Pirnia F, Bang YJ, Myers CE, Trepel JB (1992) P2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J Clin Invest 89(1):191\u2013196. https:\/\/doi.org\/10.1172\/JCI115562","journal-title":"J Clin Invest"},{"issue":"5A","key":"9785_CR178","first-page":"2853","volume":"24","author":"RC Calvert","year":"2004","unstructured":"Calvert RC, Shabbir M, Thompson CS, Mikhailidis DP, Morgan RJ, Burnstock G (2004) Immunocytochemical and pharmacological characterisation of P2-purinoceptor-mediated cell growth and death in PC-3 hormone refractory prostate cancer cells. Anticancer Res 24(5A):2853\u20132859","journal-title":"Anticancer Res"},{"issue":"1","key":"9785_CR179","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1464-410X.2008.07578.x","volume":"102","author":"M Shabbir","year":"2008","unstructured":"Shabbir M, Thompson C, Jarmulowiczc M, Mikhailidis D, Burnstock G (2008) Effect of extracellular ATP on the growth of hormone-refractory prostate cancer in vivo. BJU Int 102(1):108\u2013112","journal-title":"BJU Int"},{"issue":"2","key":"9785_CR180","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.canlet.2004.05.023","volume":"215","author":"L Chen","year":"2004","unstructured":"Chen L, He HY, Li HM, Zheng J, Heng WJ, You JF, Fang WG (2004) ERK1\/2 and p38 pathways are required for P2Y receptor-mediated prostate cancer invasion. Cancer Lett 215(2):239\u2013247. https:\/\/doi.org\/10.1016\/j.canlet.2004.05.023","journal-title":"Cancer Lett"},{"issue":"5","key":"9785_CR181","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/pros.20900","volume":"69","author":"A Minelli","year":"2009","unstructured":"Minelli A, Bellezza I, Tucci A, Rambotti MG, Conte C, Culig Z (2009) Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells. Prostate 69(5):538\u2013547. https:\/\/doi.org\/10.1002\/pros.20900","journal-title":"Prostate"},{"issue":"12","key":"9785_CR182","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1158\/1541-7786.MCR-14-0302-T","volume":"12","author":"SS Virtanen","year":"2014","unstructured":"Virtanen SS, Kukkonen-Macchi A, Vainio M, Elima K, Harkonen PL, Jalkanen S, Yegutkin GG (2014) Adenosine inhibits tumor cell invasion via receptor-independent mechanisms. Mol Cancer Res 12(12):1863\u20131874. https:\/\/doi.org\/10.1158\/1541-7786.MCR-14-0302-T","journal-title":"Mol Cancer Res"},{"issue":"1","key":"9785_CR183","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11302-018-9642-3","volume":"15","author":"CFF Gardani","year":"2019","unstructured":"Gardani CFF, Cappellari AR, de Souza JB, da Silva BT, Engroff P, Moritz CEJ, Scholl JN, Battastini AMO, Figueiro F, Morrone FB (2019) Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients. Purinergic Signal 15(1):95\u2013105. https:\/\/doi.org\/10.1007\/s11302-018-9642-3","journal-title":"Purinergic Signal"},{"issue":"5","key":"9785_CR184","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/jnci\/djq562","volume":"103","author":"M Schiffman","year":"2011","unstructured":"Schiffman M, Wentzensen N, Wacholder S, Kinney W, Gage JC, Castle PE (2011) Human papillomavirus testing in the prevention of cervical cancer. J Natl Cancer Inst 103(5):368\u2013383. https:\/\/doi.org\/10.1093\/jnci\/djq562","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"9785_CR185","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11302-015-9492-1","volume":"12","author":"E Gendaszewska-Darmach","year":"2016","unstructured":"Gendaszewska-Darmach E, Szustak M (2016) Thymidine 5'-O-monophosphorothioate induces HeLa cell migration by activation of the P2Y6 receptor. Purinergic Signal 12(2):199\u2013209. https:\/\/doi.org\/10.1007\/s11302-015-9492-1","journal-title":"Purinergic Signal"},{"issue":"Pt 24","key":"9785_CR186","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1242\/jcs.03490","volume":"120","author":"S Buvinic","year":"2007","unstructured":"Buvinic S, Bravo-Zehnder M, Boyer JL, Huidobro-Toro JP, Gonzalez A (2007) Nucleotide P2Y1 receptor regulates EGF receptor mitogenic signaling and expression in epithelial cells. J Cell Sci 120(Pt 24):4289\u20134301. https:\/\/doi.org\/10.1242\/jcs.03490","journal-title":"J Cell Sci"},{"issue":"19","key":"9785_CR187","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1091\/mbc.E14-01-0042","volume":"25","author":"A Mello Pde","year":"2014","unstructured":"Mello Pde A, Filippi-Chiela EC, Nascimento J, Beckenkamp A, Santana DB, Kipper F, Casali EA, Nejar Bruno A, Paccez JD, Zerbini LF, Wink MR, Lenz G, Buffon A (2014) Adenosine uptake is the major effector of extracellular ATP toxicity in human cervical cancer cells. Mol Biol Cell 25(19):2905\u20132918. https:\/\/doi.org\/10.1091\/mbc.E14-01-0042","journal-title":"Mol Biol Cell"},{"issue":"2","key":"9785_CR188","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1139\/bcb-2013-0051","volume":"92","author":"A Beckenkamp","year":"2014","unstructured":"Beckenkamp A, Santana DB, Bruno AN, Calil LN, Casali EA, Paccez JD, Zerbini LF, Lenz G, Wink MR, Buffon A (2014) Ectonucleotidase expression profile and activity in human cervical cancer cell lines. Biochem Cell Biol 92(2):95\u2013104. https:\/\/doi.org\/10.1139\/bcb-2013-0051","journal-title":"Biochem Cell Biol"},{"issue":"2","key":"9785_CR189","doi-asserted-by":"publisher","first-page":"201","DOI":"10.4149\/204_150723N407","volume":"63","author":"ZW Gao","year":"2016","unstructured":"Gao ZW, Wang HP, Dong K, Lin F, Wang X, Zhang HZ (2016) Adenosine inhibits migration, invasion and induces apoptosis of human cervical cancer cells. Neoplasma 63(2):201\u2013207. https:\/\/doi.org\/10.4149\/204_150723N407","journal-title":"Neoplasma"},{"key":"9785_CR190","doi-asserted-by":"publisher","first-page":"914632","DOI":"10.1155\/2015\/914632","volume":"2015","author":"PD Johann","year":"2015","unstructured":"Johann PD, Muller I (2015) Multipotent mesenchymal stromal cells: possible culprits in solid tumors? Stem Cells Int 2015:914632. https:\/\/doi.org\/10.1155\/2015\/914632","journal-title":"Stem Cells Int"},{"issue":"1","key":"9785_CR191","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s12967-016-1057-8","volume":"14","author":"M-GM De Lourdes","year":"2016","unstructured":"De Lourdes M-GM, Garcia-Rocha R, Morales-Ramirez O, Montesinos JJ, Weiss-Steider B, Hernandez-Montes J, Avila-Ibarra LR, Don-Lopez CA, Velasco-Velazquez MA, Gutierrez-Serrano V, Monroy-Garcia A (2016) Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions. J Transl Med 14(1):302. https:\/\/doi.org\/10.1186\/s12967-016-1057-8","journal-title":"J Transl Med"},{"issue":"1","key":"9785_CR192","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11302-020-09693-3","volume":"16","author":"MS Pfaffenzeller","year":"2020","unstructured":"Pfaffenzeller MS, Franciosi MLM, Cardoso AM (2020) Purinergic signaling and tumor microenvironment in cervical Cancer. Purinergic Signal 16(1):123\u2013135. https:\/\/doi.org\/10.1007\/s11302-020-09693-3","journal-title":"Purinergic Signal"},{"key":"9785_CR193","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12943-015-0472-4","volume":"14","author":"A Giannuzzo","year":"2015","unstructured":"Giannuzzo A, Pedersen SF, Novak I (2015) The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells. Mol Cancer 14:203. https:\/\/doi.org\/10.1186\/s12943-015-0472-4","journal-title":"Mol Cancer"},{"issue":"5","key":"9785_CR194","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/MPA.0000000000001055","volume":"47","author":"JH Choi","year":"2018","unstructured":"Choi JH, Ji YG, Ko JJ, Cho HJ, Lee DH (2018) Activating P2X7 receptors increases proliferation of human pancreatic cancer cells via ERK1\/2 and JNK. Pancreas 47(5):643\u2013651. https:\/\/doi.org\/10.1097\/MPA.0000000000001055","journal-title":"Pancreas"},{"key":"9785_CR195","first-page":"2328","volume-title":"Physiology of Reproduction 3rd edAcademic Press","author":"M Freeman","year":"2006","unstructured":"Freeman M (2006) Neuroendocrine control of the ovarian cycle of the rat. In: Neill J, Knobil, Neill's (eds) Physiology of Reproduction 3rd edAcademic Press, pp 2328\u20132388"},{"issue":"10177","key":"9785_CR196","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM (2019) Epithelial ovarian cancer. Lancet 393(10177):1240\u20131253. https:\/\/doi.org\/10.1016\/S0140-6736(18)32552-2","journal-title":"Lancet"},{"issue":"1","key":"9785_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13669-011-0004-1","volume":"1","author":"E Kuhn","year":"2012","unstructured":"Kuhn E, Kurman RJ, Shih IM (2012) Ovarian cancer is an imported disease: fact or fiction? Curr Obstet Gynecol Rep 1(1):1\u20139. https:\/\/doi.org\/10.1007\/s13669-011-0004-1","journal-title":"Curr Obstet Gynecol Rep"},{"issue":"11","key":"9785_CR198","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/mrd.22537","volume":"82","author":"AS Martinez-Ramirez","year":"2015","unstructured":"Martinez-Ramirez AS, Vazquez-Cuevas FG (2015) Purinergic signaling in the ovary. Mol Reprod Dev 82(11):839\u2013848. https:\/\/doi.org\/10.1002\/mrd.22537","journal-title":"Mol Reprod Dev"},{"issue":"4","key":"9785_CR199","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13402-020-00513-9","volume":"43","author":"M Yousefi","year":"2020","unstructured":"Yousefi M, Dehghani S, Nosrati R, Ghanei M, Salmaninejad A, Rajaie S, Hasanzadeh M, Pasdar A (2020) Current insights into the metastasis of epithelial ovarian cancer\u2014hopes and hurdles. Cell Oncol (Dordr) 43(4):515\u2013538. https:\/\/doi.org\/10.1007\/s13402-020-00513-9","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"9785_CR200","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0304-3835(94)90348-4","volume":"77","author":"S Batra","year":"1994","unstructured":"Batra S, Fadeel I (1994) Release of intracellular calcium and stimulation of cell growth by ATP and histamine in human ovarian cancer cells (SKOV-3). Cancer Lett 77(1):57\u201363. https:\/\/doi.org\/10.1016\/0304-3835(94)90348-4","journal-title":"Cancer Lett"},{"issue":"3","key":"9785_CR201","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0143-4160(93)90068-H","volume":"14","author":"LD Popper","year":"1993","unstructured":"Popper LD, Batra S (1993) Calcium mobilization and cell proliferation activated by extracellular ATP in human ovarian tumour cells. Cell Calcium 14(3):209\u2013218","journal-title":"Cell Calcium"},{"issue":"12","key":"9785_CR202","doi-asserted-by":"publisher","first-page":"4468","DOI":"10.1002\/jcb.26104","volume":"118","author":"AS Martinez-Ramirez","year":"2017","unstructured":"Martinez-Ramirez AS, Diaz-Munoz M, Battastini AM, Campos-Contreras A, Olvera A, Bergamin L, Glaser T, Jacintho Moritz CE, Ulrich H, Vazquez-Cuevas FG (2017) Cellular migration ability is modulated by extracellular purines in ovarian carcinoma SKOV-3 Cells. J Cell Biochem 118(12):4468\u20134478. https:\/\/doi.org\/10.1002\/jcb.26104","journal-title":"J Cell Biochem"},{"issue":"11","key":"9785_CR203","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1002\/jcb.24867","volume":"115","author":"FG Vazquez-Cuevas","year":"2014","unstructured":"Vazquez-Cuevas FG, Martinez-Ramirez AS, Robles-Martinez L, Garay E, Garcia-Carranca A, Perez-Montiel D, Castaneda-Garcia C, Arellano RO (2014) Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells. J Cell Biochem 115(11):1955\u20131966. https:\/\/doi.org\/10.1002\/jcb.24867","journal-title":"J Cell Biochem"},{"issue":"4","key":"9785_CR204","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11302-018-9622-7","volume":"14","author":"P Sureechatchaiyan","year":"2018","unstructured":"Sureechatchaiyan P, Hamacher A, Brockmann N, Stork B, Kassack MU (2018) Adenosine enhances cisplatin sensitivity in human ovarian cancer cells. Purinergic Signal 14(4):395\u2013408. https:\/\/doi.org\/10.1007\/s11302-018-9622-7","journal-title":"Purinergic Signal"},{"issue":"2","key":"9785_CR205","first-page":"129","volume":"6","author":"SF Hausler","year":"2014","unstructured":"Hausler SF, Del Barrio IM, Diessner J, Stein RG, Strohschein J, Honig A, Dietl J, Wischhusen J (2014) Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion. Am J Transl Res 6(2):129\u2013139","journal-title":"Am J Transl Res"}],"container-title":["Purinergic Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-021-09785-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11302-021-09785-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11302-021-09785-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:29:42Z","timestamp":1630484982000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11302-021-09785-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,12]]},"references-count":205,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["9785"],"URL":"https:\/\/doi.org\/10.1007\/s11302-021-09785-8","relation":{},"ISSN":["1573-9538","1573-9546"],"issn-type":[{"value":"1573-9538","type":"print"},{"value":"1573-9546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,12]]},"assertion":[{"value":"8 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors are in agreement with publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}